Skip to content
Boca Raton City Online – Lifestyle
Author:
Spyre Therapeutics, Inc.
Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
April 13, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
April 3, 2026
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
March 16, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
March 9, 2026
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
March 8, 2026
Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 7, 2026
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
March 7, 2026
Spyre Therapeutics Announces Grants of Inducement Awards
March 5, 2026
←
Previous Page
1
2